25.59
25.59 (0%)
As of Jul 12, 2024
Deciphera Pharmaceuticals, Inc. [DCPH]
Source:
Company Overview
Deciphera Pharmaceuticals, Inc is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer.
| Country | United States |
| Headquarters | waltham, massachusetts |
| Phone Number | (781) 209-6400 |
| Industry | manufacturing |
| CEO | Steven L. Hoerter |
| Website | www.deciphera.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $0 |
| Operating Profit | $0 |
| Net Income | $0 |
| Net Cash | $8.6 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | |
| Profit as % of Stockholder Equity |
Management Effectiveness
| Return on Equity | -14.3% |
| Return on Assets | -10.7% |
| Turnover Ratio | |
| EBITA |
Balance Sheet and Cash Flow Measures
| Total Assets | $420.9 |
| Total Liabilities | $104.9 |
| Operating Cash Flow | $-54.6 |
| Investing Cash Flow | $62.6 |
| Financing Cash Flow | $0.5 |
